Editors: Prof. Dr. Atta-ur-Rahman, Prof. Dr. M. Iqbal Choudhary

Anti-Obesity Drug Discovery and Development

Volume 5

eBook: US $89 Special Offer (PDF + Printed Copy): US $151
Printed Copy: US $107
Library License: US $356
ISSN: 2467-9615 (Print)
ISSN: 2210-2698 (Online)
ISBN: 978-981-14-2376-5 (Print)
ISBN: 978-981-14-2317-8 (Online)
Year of Publication: 2021
DOI: 10.2174/97898114231781200501

Introduction

Obesity is a complex health problem, caused by a number of factors such as excessive food intake, lack of physical activity, genetic predisposition, endocrine disorders, medications and psychiatric illnesses. The incidence of obesity among populations in both the developing and the developed world has reached epidemic proportions. In response to this, efforts to control and treat obesity have also been vigorously pursued, ranging from activities focused on raising awareness about lifestyle changes to the discovery and development of safe and effective anti-obesity drugs. Anti-obesity Drug Discovery and Development is a book series focused on this very important area of healthcare research. Each volume presents insightful updates on pharmaceutical research and development for clinical researchers and healthcare professionals involved in obesity treatment programs.

The fifth volume of this series is a compilation of 6 reviews of interesting topics on the subject that highlight different aspects of obesity treatment and management, some of which are novel approaches. Topics covered in this volume include:

  • - the effect of sleep on weight and obesity management
  • - AMPK as a postulated target for metabolic syndrome and obesity
  • - Harnessing addiction neuroscience to treat obesity
  • - Current treatment of obesity versus the next generation of anti-obesogenic drugs: an ecologically and sustainable approach to health
  • - Leptin and leptin sensitizers for the treatment of obesity related conditions
  • - MicroRNAs as targets for the management of obesity

Audience: Pharmaceutical chemistry researchers, clinicians and medical specialists in internal medicine, endocrinology and rehabilitation medicine

Contributors

Editor(s):
Prof. Dr. Atta-ur-Rahman
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK


Prof. Dr. M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
International Center for Chemical and Biological Sciences
University of Karachi
Karachi
Pakistan




Contributor(s):
Ankit Patel
Department of Internal Medicine
Eastern Virginia Medical School
Norfolk, VA
USA


Azahara I. Rupérez
CIBEROBN (Physiopathology of Obesity and Nutrition CB12/03/30038)
Madrid
Spain
/
Growth, Exercise, Nutrition and Development (GENUD) Research Group
University of Zaragoza
Zaragoza
Spain
/
Health Research Institute of Aragón (ISS Aragón)
Zaragoza
Spain
/

Food and Agriculture Institute of Aragón (IA2)
Zaragoza
Spain


Byung Soo Yoo
Department of Internal Medicine
Eastern Virginia Medical School
Norfolk, VA
USA


Carolina Gomez-Llorente
Department of Biochemistry and Molecular Biology 2
School of Pharmacy, Campus de Cartuja s/n. Institute of Nutrition and Food Technology “José Mataix”, University of Granada
Granada
Spain


Concepción M. Aguilera
Department of Biochemistry and Molecular Biology 2
School of Pharmacy, Campus de Cartuja s/n. Institute of Nutrition and Food Technology “José Mataix”, University of Granada
Granada
Spain
/
Instituto de investigaciones Biosanitaria. ibs.GRANADA
Granada
Spain
/
CIBEROBN (Physiopathology of Obesity and Nutrition CB12/03/30038)
Madrid
Spain



Instituto de investigaciones Biosanitaria. ibs.GRANADA
Granada
Spain
/
CIBEROBN (Physiopathology of Obesity and Nutrition CB12/03/30038)
Madrid
Spain


David Johnson
Department of Internal Medicine
Eastern Virginia Medical School
Norfolk, VA
USA
/
Department of Internal Medicine
Division of Gastroenterology, Eastern Virginia Medical School
Norfolk, VA
USA


Diana Sketriene
The Florey Institute of Neuroscience & Mental Health
Melbourne, Victoria
Australia


Francisco J. Ruiz-Ojeda
Department of Biochemistry and Molecular Biology 2
School of Pharmacy, Campus de Cartuja s/n. Institute of Nutrition and Food Technology “José Mataix”, University of Granada
Granada
Spain
/
Instituto de investigaciones Biosanitaria. ibs.GRANADA
Granada
Spain


Kevin Houston
Department of Internal Medicine
Eastern Virginia Medical School
Norfolk, VA
USA


Luísa Scheer Ely Martines
Institute of Geriatrics and Gerontology and Biomedical Gerontology Graduate Program of the School of Medicine of PUCRS
Lajeado, RS
Brazil


Maria Gabriela Valle Gottlieb
Institute of Geriatrics and Gerontology and Biomedical Gerontology Graduate Program of the School of Medicine of PUCRS,
Brazil


Mitra Nourbakhsh
Department of Biochemistry, Faculty of Medicine
Iran University of Medical Sciences
Tehran
Iran


Nujen Colak Bozkurt
Department of Endocrinology and Metabolism
Diskapi Teaching and Research Hospital
Ankara
Turkey


Parth J. Parekh
Department of Internal Medicine
Eastern Virginia Medical School
Norfolk, VA
USA
/
Department of Internal Medicine
Division of Gastroenterology, Eastern Virginia Medical School
Norfolk, VA
USA


Robyn M. Brown
The Florey Institute of Neuroscience & Mental Health
Melbourne, Victoria
Australia


Steve D’Souza
Department of Internal Medicine
Eastern Virginia Medical School
Norfolk, VA
USA


Tuncay Delibasi
Department of Endocrinology and Metabolism
Diskapi Teaching and Research Hospital
Ankara
Turkey
/
Department of Internal Medicine, School of Medicine
Hacettepe University
Ankara
Turkey


Vilma Maria Junges
Integrated Center for Obesity Treatment (CINTRO)
Porto Alegre, RS
Brazil




RELATED BOOKS

.Key Heterocyclic Cores for Smart Anticancer Drug–Design Part II.
.Key Heterocyclic Cores for Smart Anticancer Drug–Design Part I.
.Frontiers in Cardiovascular Drug Discovery.
.Frontiers in Drug Design and Discovery.